Literature DB >> 26233693

Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression.

Hannah M Kersten1, Helen V Danesh-Meyer2, Dean H Kilfoyle3,4, Richard H Roxburgh5,6.   

Abstract

Previous reports of ocular abnormalities in Huntington's disease (HD) have detailed eye movement disorders. The objective of this case-control study was to investigate optic nerve and macular morphology in HD using optical coherence tomography (OCT). A total of 26 HD patients and 29 controls underwent a thorough ophthalmic examination including spectral domain OCT scans of the macula and peripapillary retinal nerve fibre layer (RNFL). Genetic testing results, disease duration, HD disease burden scores and Unified HD Rating Scale motor scores were acquired for HD patients. Temporal RNFL thickness was significantly reduced in the HD group (62.3 vs. 69.8 μm, p = 0.005), and there was a significant negative correlation between temporal RNFL thickness and disease duration (R (2) = -0.51, p = 0.04). Average peripapillary RNFL thickness was not significantly different between the HD and control groups. There was a significant negative correlation between macular volume and disease duration (R (2) = -0.71, p = 0.002), and motor scores (R (2) = -0.56, p = 0.01). Colour vision was significantly poorer in the HD group. Temporal RNFL is preferentially thinned in HD patients, possibly implicating mitochondrial dysfunction as the temporal RNFL is reduced in the patients with some mitochondrial disorders, including Leber's hereditary optic neuropathy. The correlation between the decrease in macular volume and temporal RNFL, and increasing disease severity suggests that OCT may be a useful biomarker for disease progression in HD. Larger, longitudinal studies are required.

Entities:  

Keywords:  Huntington’s disease; Macula; Optical coherence tomography; Retina; Retinal nerve fiber layer

Mesh:

Substances:

Year:  2015        PMID: 26233693     DOI: 10.1007/s00415-015-7869-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  49 in total

1.  Optical coherence tomography as a potential readout in clinical trials.

Authors:  Benjamin M Greenberg; Elliot Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

2.  Is the retina affected in Huntington disease?

Authors:  Elisabeth Petrasch-Parwez; Carsten Saft; Annegrit Schlichting; Jürgen Andrich; Markus Napirei; Larissa Arning; Stefan Wieczorek; Rolf Dermietzel; Jörg Thomas Epplen
Journal:  Acta Neuropathol       Date:  2005-10-13       Impact factor: 17.088

Review 3.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

4.  Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy.

Authors:  Piero Barboni; Giacomo Savini; Maria Lucia Valentino; Pasquale Montagna; Pietro Cortelli; Anna Maria De Negri; Federico Sadun; Stefania Bianchi; Lora Longanesi; Maurizio Zanini; Antonello de Vivo; Valerio Carelli
Journal:  Ophthalmology       Date:  2005-01       Impact factor: 12.079

5.  Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients.

Authors:  M Satue; E Garcia-Martin; I Fuertes; S Otin; R Alarcia; R Herrero; M P Bambo; L E Pablo; F J Fernandez
Journal:  Eye (Lond)       Date:  2013-02-22       Impact factor: 3.775

6.  Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.

Authors:  Stephan Klebe; Christel Depienne; Sylvie Gerber; Georges Challe; Mathieu Anheim; Perrine Charles; Estelle Fedirko; Elodie Lejeune; Julien Cottineau; Alfredo Brusco; Hélène Dollfus; Patrick F Chinnery; Cecilia Mancini; Xavier Ferrer; Guilhem Sole; Alain Destée; Jean-Michel Mayer; Bertrand Fontaine; Jérôme de Seze; Michel Clanet; Elisabeth Ollagnon; Philippe Busson; Cécile Cazeneuve; Giovanni Stevanin; Josseline Kaplan; Jean-Michel Rozet; Alexis Brice; Alexandra Durr
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

Review 7.  Advancing therapeutic options in multiple sclerosis with neuroprotective properties.

Authors:  Anke Stroet; Ralf A Linker; Ralf Gold
Journal:  J Neural Transm (Vienna)       Date:  2013-05-30       Impact factor: 3.575

Review 8.  Huntington's disease: pathogenesis, diagnosis and treatment.

Authors:  S E Purdon; E Mohr; V Ilivitsky; B D Jones
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

Review 9.  Disorders of the optic nerve in mitochondrial cytopathies: new ideas on pathogenesis and therapeutic targets.

Authors:  Kamil S Sitarz; Patrick F Chinnery; Patrick Yu-Wai-Man
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

10.  Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.

Authors:  Symantas Ragauskas; Henri Leinonen; Jooseppi Puranen; Seppo Rönkkö; Soile Nymark; Kestutis Gurevicius; Arto Lipponen; Outi Kontkanen; Jukka Puoliväli; Heikki Tanila; Giedrius Kalesnykas
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

View more
  24 in total

1.  Huntington's disease and neurovascular structure of retina.

Authors:  Elahe Amini; Mehdi Moghaddasi; Seyed Amir Hassan Habibi; Zahra Azad; Shahnaz Miri; Naveed Nilforushan; Reza Mirshahi; Esther Cubo; Nahid Mohammadzadeh; Mohammad Rohani
Journal:  Neurol Sci       Date:  2022-06-30       Impact factor: 3.830

2.  Light-Sheet Microscopy of the Optic Nerve Reveals Axonal Degeneration and Microglial Activation in NMDA-Induced Retinal Injury.

Authors:  Yonju Ha; Lorenzo F Ochoa; Olivia Solomon; Shuizhen Shi; Paula P Villarreal; Shengguo Li; Seth Buscho; Gracie Vargas; Wenbo Zhang
Journal:  EC Ophthalmol       Date:  2021-10-28

Review 3.  An Eye on Movement Disorders.

Authors:  Duncan Wilson; Mark Hallett; Tim Anderson
Journal:  Mov Disord Clin Pract       Date:  2021-08-10

4.  Retinal dysfunction in a presymptomatic patient with Huntington's disease.

Authors:  Jonelle Knapp; Dean A VanNasdale; Keith Ramsey; Julie Racine
Journal:  Doc Ophthalmol       Date:  2018-04-24       Impact factor: 2.379

5.  Contrast Acuity and the King-Devick Test in Huntington's Disease.

Authors:  Ali G Hamedani; Tanya Bardakjian; Laura J Balcer; Pedro Gonzalez-Alegre
Journal:  Neuroophthalmology       Date:  2019-11-25

Review 6.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

Review 7.  Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies.

Authors:  Chiara La Morgia; Lidia Di Vito; Valerio Carelli; Michele Carbonelli
Journal:  Front Neurol       Date:  2017-12-22       Impact factor: 4.003

Review 8.  Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors:  Jonah Doustar; Tania Torbati; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Front Neurol       Date:  2017-12-19       Impact factor: 4.003

9.  Influence of cardiovascular condition on retinal and retinal nerve fiber layer measurements.

Authors:  Elena Garcia-Martin; Erika Ruiz-de Gopegui; Montserrat León-Latre; Sofia Otin; Irene Altemir; Vicente Polo; Jose M Larrosa; Marta Cipres; Jose A Casasnovas; Luis E Pablo
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

Review 10.  Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and Beyond.

Authors:  Chiara La Morgia; Fred N Ross-Cisneros; Alfredo A Sadun; Valerio Carelli
Journal:  Front Neurol       Date:  2017-05-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.